Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Liver Transpl
; 29(5): 559-563, 2023 05 01.
Article
in En
| MEDLINE
| ID: mdl-36747351
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Liver Transplantation
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
Liver Transpl
Journal subject:
GASTROENTEROLOGIA
/
TRANSPLANTE
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: